dan 2163 has been researched along with Drooling in 7 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The beneficial effect of sulpiride augmentation of clozapine therapy for treatment-resistant schizophrenia patients is enhanced by its antisalivatory effect on clozapine-induced hypersalivation (CIH)." | 9.12 | Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study. ( Kreinin, A; Novitski, D; Weizman, A, 2006) |
| "Amisulpride is suggested for treatment of clozapine-induced sialorrhea." | 7.78 | Atypical antipsychotics--effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea. ( Ekström, J; Godoy, T; Riva, A, 2012) |
| "Treatment of drug-induced sialorrhea based on case reports and clinical studies were sought in May 2021 from PubMed, Google Scholar and Science Direct (keywords : « treatment », « hypersalivation », « induced », « drug », « clozapine »)." | 5.22 | [Treatment options for drug-induced sialorrhea: Prescribing guidelines]. ( Amad, A; Cuvelier, E; Décaudin, B; Fovet, T; Gressier, B; Simon, N, 2022) |
| "The study was designed as a 6-week, two-center, fixed-dose, comparison study of 400 mg/day of amisulpride versus 300 mg/day of moclobemide as an adjunctive treatment in 53 schizophrenia and schizoaffective disorder patients (diagnosed according to DSM-IV) suffering from CIS." | 5.15 | Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation. ( Bergman, J; Kreinin, A; Lerner, V; Libov, I; Miodownik, C; Shestakova, D; Sokolik, S, 2011) |
| "The beneficial effect of sulpiride augmentation of clozapine therapy for treatment-resistant schizophrenia patients is enhanced by its antisalivatory effect on clozapine-induced hypersalivation (CIH)." | 5.12 | Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study. ( Kreinin, A; Novitski, D; Weizman, A, 2006) |
| "Amisulpride is suggested for treatment of clozapine-induced sialorrhea." | 3.78 | Atypical antipsychotics--effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea. ( Ekström, J; Godoy, T; Riva, A, 2012) |
| "The side effects, especially hypersalivation, disappeared almost entirely, which in turn led to good compliance." | 1.33 | Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report. ( Croissant, B; Hermann, D; Olbrich, R, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Cuvelier, E | 1 |
| Gressier, B | 1 |
| Fovet, T | 1 |
| Simon, N | 1 |
| Décaudin, B | 1 |
| Amad, A | 1 |
| Praharaj, SK | 1 |
| Sarkar, S | 1 |
| Sinha, VK | 1 |
| Aggarwal, A | 1 |
| Sharma, DD | 1 |
| Kreinin, A | 2 |
| Miodownik, C | 1 |
| Sokolik, S | 1 |
| Shestakova, D | 1 |
| Libov, I | 1 |
| Bergman, J | 1 |
| Lerner, V | 1 |
| Godoy, T | 1 |
| Riva, A | 1 |
| Ekström, J | 1 |
| Croissant, B | 1 |
| Hermann, D | 1 |
| Olbrich, R | 1 |
| Novitski, D | 1 |
| Weizman, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Benzamide Derivates (Amisulpride, Moclobemide and Tiapride) as Treatment of Clozapine-induced Hypersalivation: Pilot Double Phase Study: Open and Double-blind[NCT00534573] | Phase 3 | 54 participants (Actual) | Interventional | 2008-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dan 2163 and Drooling
| Article | Year |
|---|---|
[Treatment options for drug-induced sialorrhea: Prescribing guidelines].
Topics: Amisulpride; Antipsychotic Agents; Cholinergic Antagonists; Clozapine; Female; Humans; Male; Quality | 2022 |
2 trials available for dan 2163 and Drooling
| Article | Year |
|---|---|
Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
Topics: Adult; Aged; Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Female; Humans; Male; | 2011 |
Amisulpride treatment of clozapine-induced hypersalivation in schizophrenia patients: a randomized, double-blind, placebo-controlled cross-over study.
Topics: Amisulpride; Antipsychotic Agents; Clozapine; Cross-Over Studies; Double-Blind Method; Female; Human | 2006 |
4 other studies available for dan 2163 and Drooling
| Article | Year |
|---|---|
Amisulpride treatment for clozapine-induced sialorrhea.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Anta | 2009 |
Amisulpride for clozapine induced sialorrhea.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Female; Humans; Sialorrhea; Sulpiride | 2009 |
Atypical antipsychotics--effects of amisulpride on salivary secretion and on clozapine-induced sialorrhea.
Topics: Amisulpride; Amylases; Animals; Antipsychotic Agents; Autonomic Agents; Bethanechol; Clozapine; Dene | 2012 |
Reduction of side effects by combining clozapine with amisulpride: case report and short review of clozapine-induced hypersalivation-a case report.
Topics: Adult; Amisulpride; Antipsychotic Agents; Clozapine; Drug Therapy, Combination; Humans; Male; Schizo | 2005 |